Galectin Therapeutics Inc (GALT) Price Targets From Analysts
Use the tables below to see what analysts covering Galectin Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
GALT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- GALT has a higher number of analysts covering the stock than practically none of all US stocks.
- The variance in analysts' estimates of GALT is lower than almost 100% of all US stocks.
- Galectin Therapeutics Inc's percent of analysts bearish on the stock is less than almost 100% of all US stocks.
- The upside potential (average analyst target price relative to current price) of GALT is higher than 94.36% of all US stocks.
- GALT has a higher percentage of analysts bullish on the stock than 82.08% of all US stocks.
- The average analyst price target of GALT is greater than 26.35% of all US stocks.
- The change in bullishness amongst analysts of GALT is less than almost 100% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Galectin Therapeutics Inc are PLX, ONCT and AMPE.
Is GALT a Buy, Hold or Sell? See the POWR Ratings now!